Mutations of the connexin 37 and 40 gap-junction genes in patients with acute myocardial infarction

Clinical Laboratory

Volumn 59, Issue 3-4, 2013, Pages 343-348

  Seifi, Morteza ^a   Fallah, Soudabeh ^a   Ghasemi, Asghar ^a   Aghajani, Hasan ^b   Razaghi, Maliheh ^a   Danaei, Nasim ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 37; CONNEXIN 40;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; CONNEXINS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876512144     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120305     Document Type: Article

References (34)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
2. Jefferson BK, Topol EJ. Molecular mechanisms of myocardial infarction. Curr Probl Cardiol 2005;30:333-74.
3. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772-8.
4. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 2004;110:1868-73.
5. Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M. Genetic risk for coronary artery disease in individuals with or without type 2 diabetes. Mol Genet Metab 2004;81:282-90.
6. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002;22:225-30.
7. Wong CW, Christen T, Kwak BR. Connexins in leukocytes: shuttling messages? Cardiovasc Res 2004;62:357-67.
8. Liao Y, Day KH, Damon DN, Duling BR. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci U S A 2001;98:9989-94.
9. Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ. Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res. 1998;83:1248-63.
10. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin 37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 2007;191:355-61.
11. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999;99:1508-15.
12. Verheule S, van Batenburg CA, Coenjaerts FE, Kirchhoff S, Willecke K, Jongsma HJ. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J Cardiovasc Electrophysiol 1999;10:1380-9.
13. Bevilacqua LM, Simon AM, Maguire CT, et al. A targeted disruption in connexin 40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol 2000;4:459-67.
14. Van der Velden HM, Ausma J, Rook MB, et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000;46:476-86.
15. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79.
16. Groenewegen WA, Firouzi M, Bezzina CR, et al. A cardiac sodium channel mutation cosegregates with a rare connexin 40 genotype in familial atrial standstill. Circ Res 2003;92:14-22.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:121-5.
18. Boerma M, Forsberg L, Van Zeijl L. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999;246:211-8.
19. Listì F, Candore G, Lio D, et al. Association between C1019T polymorphism of connexin 37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 2005;102:269-71.
20. Yeh H-I, Chou Y, Liu H-F, Chang S-C, Tsai C-H. Connexin 37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 2001;81:251-5.
21. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;24:1916-23.
22. Richard G, Lin J-P, Smith L, et al. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity, and analysis of candidate genes. J Invest Dermatol 1997;109:666-71.
23. Yeh HI, Chou Y, Liu HF, Chang SC, Tsai CH. Connexin 37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 2001;81:251-5.
24. Hirashiki A, Yamada Y, Murase Y, et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42:1429-37.
25. Guetta V, Cannon RO. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996;93:1928-37.
26. Yeh HI, Chang HM, Lu WW, et al. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 2000;48:1377-89.
27. Reed KE, Westphale EH, Larson DM, Wang H, Veenstra RD, Beyer EC. Molecular cloning and functional expression of human connexin 37 and endothelial cell gap junction protein. J Clin Investigations 1993;91:997-1004.
28. Cooper CD, Solan JL, Dolejsi MK, Lampe PD. Analysis of connexin phosphorylation sites. Methods 2000;20:196-204.
29. Firouzi M, Ramanna H, Kok B, et al. Association of human connexin 40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004;95:29-33.
30. Linhares VL, Almeida NA, Menezes DC, et al. Transcriptional regulation of the murine Connexin 40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res 2004;64:402-11.
31. Chaldoupi SM, Loh P, Hauer RN, de Bakker JM, van Rijen HV. The role of connexin 40 in atrial fibrillation. Cardiovasc Res 2009;84:15-23.
32. Hauer RN, Groenewegen WA, Firouzi M, Ramanna H, Jongsma HJ. Cx40 Polymorphism in Human Atrial Fibrillation. Adv Cardiol 2006;42:284-91.
33. Gu H, Smith FC, Taffet SM, Delmar M. High incidence of cardiac malformations in connexin 40-deficient mice. Circ Res 2003;93:201-6.
34. Christiansen J, Dyck JD, Elyas BG, et al. Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res 2004;94:1429-35.